Pedro Barata
Director, Clinical Genitourinary Medical Oncology Research Program, UH Seidman Cancer Center · Case Western Reserve University/University Hospitals Cleveland Medical Center
Credentials: · · · · · · · ·
History
PresentClinical Genitourinary Medical Oncology Research Program · Case Western Reserve University/University Hospitals Cleveland Medical Center
- Present
University Hospitals Department · Case Western Reserve University/University Hospitals Cleveland Medical Center
- Present
Clinical Genitourinary Medical Oncology Research Center · Case Western Reserve University/University Hospitals Cleveland Medical Center
2016–2018- 2013–2016
Medical Oncology
- 2005–2009
Research
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Review · Cancer Treatment Reviews · 2016 · First of 3 authors · 113 citations
Journal for ImmunoTherapy of Cancer · 2020 · First of 16 authors · Corresponding · 108 citations
Cancer · 2020 · 86 citations
23 papers · 5 as a resident
19 papers
16 papers
16 papers
15 papers · 2 as a fellow
- AA
14 papers
14 papers
14 papers · 2 as a fellow
Grants
- 1997–2030
Case Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $178K · Case Western Reserve University
Clinical trials
- 2026–2030
Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer
Principal investigator · Not yet recruiting · Phase 2
Pedro Barata, MD, MSc
- 2025–2026
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Principal investigator · Recruiting · Phase 2
Case Comprehensive Cancer Center
- 2024–2025
Principal investigator · Completed · Phase 2
Pedro Barata, MD, MSc
- 2024–2027
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Site PI · Recruiting · Phase 1
Full-Life Technologies UK Limited